Assignee
ZENTIVA AS
CZ·9 granted patents·4 pending applications·21 citations·filing 2001–2005
Top patents by PatentIndex Score
13 records- 0171US7619087B2Method of preparation of oxycodoneZENTIVA AS·Filed 2005·Granted Nov 17, 2009·8 cites·15 claims
- 0263US7618953B2Amorphous forms of risedronate monosodiumZENTIVA AS·Filed 2005·Granted Nov 17, 2009·1 cites·19 claims
- 0358US7208608B2Method of manufacturing an amorphous form of the hemi-calcium salt of (3R,5R) 7-3-phenyl-4-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-pyrrol-1-yll-3, 5-dihydroxyheptanoic acid (actorvastatin)ZENTIVA AS·Filed 2003·Granted Apr 24, 2007·6 cites·4 claims
- 0455US7544840B2Method of production of (−)-(S)-3-[1-(dimethylamino)ethyl]phenyl-N-ethyl-N-methylcarbamateZENTIVA AS·Filed 2003·Granted Jun 9, 2009·2 cites·11 claims
- 0554US7276604B2Crystalline form of the sodium salt of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acidZENTIVA AS·Filed 2003·Granted Oct 2, 2007·2 cites·11 claims
- 0640US7009057B2Method for obtaining pioglitazone as an antidiabetic agentZENTIVA AS·Filed 2002·Granted Mar 7, 2006·2 cites·15 claims
- 0739US7282517B2Method of manufacturing glimepiride and the respective intermediateZENTIVA AS·Filed 2004·Granted Oct 16, 2007·0 cites·18 claims
- 0837US2005245742A1Process for the preparation of zaleplonZENTIVA AS·Filed 2005·Application pending·0 cites
- 0934US2009192318A1Method of preparation of N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-y1) [1,1'-biphenyl]-4-y1]methyl]-L-valine (valsartan)ZENTIVA AS·Filed 2004·Application pending·0 cites
- 1034US2008171784A1Methods For the Stabilization of AtorvastatinZENTIVA AS·Filed 2004·Application pending·0 cites
- 1133US2007155765A1Method of preparation of the hemi-calcium salt of (e)-7-[4-(4fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonvl)aminolpyrimidin-5-yl](3r,5s)-3,5-, dihvdroxy-6-heptenoic acidZENTIVA AS·Filed 2004·Application pending·0 cites
- 1230US7534895B2Process for preparation of carvedilolZENTIVA AS·Filed 2003·Granted May 19, 2009·0 cites·16 claims
- 1329US7198802B2Tablet obtained by direct compression comprising 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid as active ingredientZENTIVA AS·Filed 2001·Granted Apr 3, 2007·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →